Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vicente Torres, MD, PhD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Renal Research - Gosford
Gosford, New South Wales, Australia
- University Multiprofile Hospital for Active Treatment
Pleven, Bulgaria
- Medical Center "hipokrat - N"
Plovdiv, Bulgaria
- University Multiprofile Hospital for Active Treatment - Kaspela
Plovdiv, Bulgaria
- Kidney Center - Medical Center
Varna, Bulgaria
- Multi-Profile Hospital for Active Treatment Sveta Anna - Varna
Varna, Bulgaria
- Bajai Szent Rokus Korhaz
Baja, Hungary
- Semmelweis Egyetem
Budapest, Hungary
- Debreceni Egyetem
Debrecen, Hungary
- Bugat Pal Korhaz
Gyöngyös, Hungary
- University of Pecs
Pécs, Hungary
- Scm Spolka Z O.O
Krakow, Poland
- Provita Centrum Medyczne Sp. Z O.O.
Warsaw, Poland
- Hospital Universitari de Bellvitge (hub)
Barcelona, Spain
- Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain
- T.R. Ministry of Health Ankara Training and Research Hospital (internal Disease, Division of Nephrology)
Ankara, Turkey (Türkiye)
- Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi
Fatih, Turkey (Türkiye)
- Istanbul Universitesi - Cerrahpasa Tip Fakultesi Hastanesi (iuctfh)
Fatih, Turkey (Türkiye)
- Erciyes Universitesi Tip Fakultesi (erciyes University Faculty of Medicine) (internal Medicine; Nephrology)
Kayseri, Turkey (Türkiye)
- Salford Royal Nhs Foundation Trust
Salford, United Kingdom
- Nephrology Associates, Pc - Greystone
Hoover, Alabama, United States
- Nephrology Consultants, Llc
Huntsville, Alabama, United States
- Arizona Kidney Disease & Hypertension Center - Scottsdale / Pima
Scottsdale, Arizona, United States
- Jem Research Institute
Atlantis, Florida, United States
- Elixia at Florida Kidney Physicians - Southeast
Fort Lauderdale, Florida, United States
- Qway Research
Hialeah, Florida, United States
- South Florida Nephrology Associates Pa
Lauderdale Lakes, Florida, United States
- Total Research Group, Llc
Miami, Florida, United States
- Innovation Medical Research Center, Inc
Palmetto Bay, Florida, United States
- Florida Kidney Physicians - Tampa
Tampa, Florida, United States
- Clinical Site Partners, Llc
Winter Park, Florida, United States
- Tufts Medical Center, Inc,
Boston, Massachusetts, United States
- St Clair Nephrology Research, Llc
Roseville, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Clinical Research Consultants, Llc
Kansas City, Missouri, United States
- Angel City Research, Inc
Morrisville, North Carolina, United States
- Northeast Clinical Research Center, Llc
Bethlehem, Pennsylvania, United States
- Brown Medicine - Brown Physicians Patient Center
Riverside, Rhode Island, United States
- Knoxville Kidney Center Llc
Knoxville, Tennessee, United States
- Prolato Clinical Research Center (pcrc)
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Oct 2021
- Primary completion
- 3 Aug 2022
- Completion
- 3 Aug 2022
- Last update posted
- 6 Feb 2023
- Registered enrollment
- 12
- Registry id
- NCT04064346
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.